Latest Articles

Publication Date
All News Scientific
Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed? - simplywall.st

Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed? simplywall.st

Published: June 25, 2026, 2:25 a.m.
Read Full Article
Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) Seeking Alpha

Published: June 24, 2026, 7:18 p.m.
Read Full Article
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - markets.businessinsider.com

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) markets.businessinsider.com

Published: June 24, 2026, 11:25 a.m.
Read Full Article
Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa

Absci stock surges 24% on positive Phase 1 hair loss drug data Investing.com South Africa

Published: June 24, 2026, 11:14 a.m.
Read Full Article
Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com - Investing.com India

Absci stock surges 24% on positive Phase 1 hair loss drug data By Investing.com Investing.com India

Published: June 24, 2026, 11:13 a.m.
Read Full Article
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - The Manila Times

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) The Manila Times

Published: June 24, 2026, 10:48 a.m.
Read Full Article
Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart - Minichart

Absci Reports Positive Phase 1 Results for ABS-201, a First-in-Class PRLR Antibody for Hair Regrowth and Endometriosis – Minichart Minichart

Published: June 24, 2026, 10:45 a.m.
Read Full Article
Taking the combined oral contraceptive pill can increase binge eating, study suggests - MSN

Taking the combined oral contraceptive pill can increase binge eating, study suggests MSN

Published: June 24, 2026, 10:43 a.m.
Read Full Article
Catheter-Based OCT May Help ID Early Endometrial Cancer - Ophthalmology Advisor

Catheter-Based OCT May Help ID Early Endometrial Cancer Ophthalmology Advisor

Published: June 24, 2026, 4 a.m.
Read Full Article
TIUMBIO CEO Hun-Taek Kim Purchases 300 Million Won Worth of Shares on the Open Market - 아시아경제

TIUMBIO CEO Hun-Taek Kim Purchases 300 Million Won Worth of Shares on the Open Market 아시아경제

Published: June 23, 2026, 11:36 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!